Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
The aim of the present study is to evaluate the feasibility of 123I-IBZM (a D2 agonist radiolabelled with 123I) in patients with PHEO and/or PGL. Diagnostic accuracy will be also compared to traditional SPECT imaging procedures.
Assistance Publique Hopitaux De Marseille
France: Ministry of Health